Developer docs
API playgroundTry for free, no card

Search company profiles

BrainEye

Full company profile

uuid00ernki

Namestring
BrainEye
Legal namestring
Neuro Optica Operations Pty Ltd ACN 669 149 884
Websiteurl
braineye.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

BrainEye (formerly BioEye), operated by Neuro Optica Operations Pty Ltd (ACN 669 149 884), is a Sydney-based healthtech company founded in 2020 that provides smartphone-based eye-tracking software for brain health assessment. The core product is a mobile application that uses a smartphone camera to capture eye movements in response to visual stimuli and extract ocular motor biomarkers in approximately 60 seconds, surfacing results that may indicate changes associated with concussions, multiple sclerosis, Parkinson's disease, Alzheimer's disease, and other neurological conditions. The technology has been validated against scientific-grade eye trackers and through clinical trials overseen by the Monash University Neuroscience Department, with ethics approval from the Bellberry Human Research Ethics Committee.

Short descriptiontext

BrainEye is a Sydney-based healthtech company offering a smartphone eye-tracking app that delivers 60-second brain health assessments, targeting consumers, collision-sport athletes, and neurological-condition patients via a freemium subscription distributed through app stores.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSydney, Australia
HQ citystring
Sydney
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
smartphone eye tracking, brain health assessment, ocular motor biomarkers, concussion detection, neurological digital biomarkers
Industry3 codes
PRIMARYHLALAGAC
Neurology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYMPAAALAN
Behavioral & Neuroscience Research (Biometrics, Eye-Tracking, Neuromarketing)
NAICS code1 code
  • Offices of Optometrists621320
SIC code1 code
  • Optical Instruments & Lenses3827
Product category
Digital Health Brain Assessment Software
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1App Subscription
TypeSubscription Recurring
Description

BrainEye generates revenue through 12-month subscription plans for app access. Subscriptions extend for 12 months from registration and automatically renew unless cancelled. Pricing varies by region and subscription type. Subscribers receive access to the BrainEye app, brain health tests, and result tracking.

braineye.com
2In-App Purchases
TypeSubscription Recurring
Description

Subscriptions can be purchased as In-App Purchases via Apple App Store or Google Play Store. Users must manage cancellations through the respective platform's subscription management system.

braineye.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details2 tiers
1Standard 12-month subscription with automatic renewal
ModelSubscriptionBilling cadenceAnnual
Notes

Prices vary by region. All costs are billed in the local currency set by the device's app store settings. No refunds for unused periods, accidental purchases, or medical conditions.

braineye.com
2Free basic access with premium subscription for full features
ModelFreemiumBilling cadenceAnnual
Notes

The app is available for download with some functionality accessible without payment. Full brain health tracking features require subscription.

braineye.com
GTM typeB2C
B2C
Offering typeSoftware
Software
Core offering1 text field

BrainEye offers a smartphone-based eye-tracking application that measures brain health by tracking eye responses to visual stimuli in 60 seconds. The app captures ocular motor biomarkers via the smartphone camera, uploads them to a cloud platform, and applies AI/ML analysis to deliver real-time results that can indicate concussions, multiple sclerosis, Parkinson's disease, Alzheimer's disease, and other neurological conditions. Users subscribe via the Apple App Store or Google Play Store, with optional participation in clinical research through a separate research platform.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Traditional neurological examination evaluates approximately 10% of the brain, while BrainEye's assessment of the visual-ocular motor system evaluates over 50% of the brain
+1 more record
Product overview1 text field

BrainEye offers a mobile health technology platform centered on its smartphone-based eye-tracking application for brain health assessment. The core BrainEye App connects to the BrainEye Cloud Platform, which processes eye movement data and applies machine learning algorithms to detect brain health changes. An optional Research Platform module enables clinical research participation. The platform's primary test modality is the Smooth Pursuit (SMP) test, which captures ocular motor biomarkers to assess brain function. The company also operates a concussion research program conducted in partnership with Monash University.

Product and service1 record
1BrainEye App
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1Monash University Neuroscience Department
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Monash University Neuroscience Department conducts independent research overseeing BioEye concussion trials. The partnership involves clinical validation of the BrainEye technology platform through rigorous scientific research.

braineye.com
Strategic tierCoreTypeTechnology or Integration
Description

BrainEye processes and stores all data, including Personal Information, on secure AWS cloud servers. AWS provides the cloud infrastructure for the company's data processing, storage, and analysis operations.

3Bellberry Human Research Ethics Committee
Strategic tierCoreTypeOthers
Description

The Bellberry Human Research Ethics Committee in Australia has reviewed and approved BrainEye's clinical research studies in accordance with the Australian National Statement on Ethical Conduct in Human Research.

braineye.com
4Emmanuel Petit
Strategic tierMinorTypeGTM or Marketing Partner
Description

Iconic French footballer and World Cup champion Emmanuel Petit serves as BrainEye Brand Ambassador, bringing global recognition and commitment to excellence to the mission of revolutionizing brain health. His advocacy helps connect with a wider audience, spreading awareness about managing brain health.

braineye.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Eye-tracking concussion and neurological diagnostic platform (e.g., Eye-Sync/BOXS) commercialized to clinics and sports organizations — comparable eye-tracking modality and concussion GTM.

TypeDirect peer
Description

Eye-tracking based health-assessment company whose core technology analyses ocular motility for brain/performance diagnostics — directly comparable to BrainEye's smooth-pursuit, ocular-motor biomarker approach.

TypeDirect peer
Description

Smartphone-based cognitive and neurological assessment platform using AI/ML on consumer devices to detect and monitor conditions such as depression, MS, and Alzheimer's — the closest direct competitor to BrainEye in modality and target.

TypeBroad incumbent
Description

Public digital-therapeutics company with FDA-cleared, consumer-delivered cognitive assessment/intervention products; competes for the same at-home, smartphone-delivered brain-health user.

TypeDirect peer
Description

Eye-tracking derived balance/concussion assessment tool used by sports teams and clinicians; the closest direct competitor in the sports/concussion sub-segment BrainEye explicitly targets.

TypeBroad incumbent
Description

Established cognitive testing company serving clinical trials and healthcare providers; an incumbent in computerized brain-health assessment overlapping BrainEye's neurological-monitoring value proposition.

TypeEmerging player
Description

Brain-training and cognitive-assessment platform targeting healthy-aging and clinical populations; overlaps BrainEye on longitudinal brain-health tracking and consumer health positioning.

TypeDirect peer
Description

Digital brain-health platform combining smartphone/tablet-based cognitive and speech assessment with AI for early detection of neurological impairment; overlaps BrainEye on smartphone-delivered, AI-analyzed brain biomarkers.

TypeBroad incumbent
Description

Provider of digital cognitive assessments used in clinical trials and research; comparable in the digital brain-health assessment and trials-services category.

TypeBroad incumbent
Description

Platform incumbent that ships eye-tracking, on-device ML, and a Health ecosystem across iPhone and Vision Pro — a primary platform risk for any smartphone/eye-tracking health play.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BrainEye

Digital Health Brain Assessment Softwarebraineye.com

BrainEye is a Sydney-based healthtech company offering a smartphone eye-tracking app that delivers 60-second brain health assessments, targeting consumers, collision-sport athletes, and neurological-condition patients via a freemium subscription distributed through app stores.

What BrainEye does

BrainEye (formerly BioEye), operated by Neuro Optica Operations Pty Ltd (ACN 669 149 884), is a Sydney-based healthtech company founded in 2020 that provides smartphone-based eye-tracking software for brain health assessment. The core product is a mobile application that uses a smartphone camera to capture eye movements in response to visual stimuli and extract ocular motor biomarkers in approximately 60 seconds, surfacing results that may indicate changes associated with concussions, multiple sclerosis, Parkinson's disease, Alzheimer's disease, and other neurological conditions. The technology has been validated against scientific-grade eye trackers and through clinical trials overseen by the Monash University Neuroscience Department, with ethics approval from the Bellberry Human Research Ethics Committee.

BrainEye firmographics

Firmographics
Name
BrainEye
Legal name
Neuro Optica Operations Pty Ltd ACN 669 149 884
Website
https://braineye.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
BrainEye is a Sydney-based healthtech company offering a smartphone eye-tracking app that delivers 60-second brain health assessments, targeting consumers, collision-sport athletes, and neurological-condition patients via a freemium subscription distributed through app stores.
Ownership category
akta.pro rank

BrainEye industry classification

Industry
Product category
Digital Health Brain Assessment Software
NAICS
Offices of Optometrists (621320)
SIC
Optical Instruments & Lenses (3827)
akta.pro industry
PRIMARYHLALAGAC
Neurology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYMPAAALAN
Behavioral & Neuroscience Research (Biometrics, Eye-Tracking, Neuromarketing)

Keywords

  • Smartphone eye tracking
  • Brain health assessment
  • Ocular motor biomarkers
  • Concussion detection
  • Neurological digital biomarkers

Where BrainEye is headquartered

Location

Headquarters

HQ city
Sydney
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

BrainEye business model

Business model
GTM type
B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. App Subscription: BrainEye generates revenue through 12-month subscription plans for app access. Subscriptions extend for 12 months from registration and automatically renew unless cancelled. Pricing varies by region and subscription type. Subscribers receive access to the BrainEye app, brain health tests, and result tracking.
  2. In-App Purchases: Subscriptions can be purchased as In-App Purchases via Apple App Store or Google Play Store. Users must manage cancellations through the respective platform's subscription management system.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualStandard 12-month subscription with automatic renewal
FreemiumAnnualFree basic access with premium subscription for full features

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

BrainEye product offering

Product offering

Core offering

BrainEye offers a smartphone-based eye-tracking application that measures brain health by tracking eye responses to visual stimuli in 60 seconds. The app captures ocular motor biomarkers via the smartphone camera, uploads them to a cloud platform, and applies AI/ML analysis to deliver real-time results that can indicate concussions, multiple sclerosis, Parkinson's disease, Alzheimer's disease, and other neurological conditions. Users subscribe via the Apple App Store or Google Play Store, with optional participation in clinical research through a separate research platform.

Product overview

BrainEye offers a mobile health technology platform centered on its smartphone-based eye-tracking application for brain health assessment. The core BrainEye App connects to the BrainEye Cloud Platform, which processes eye movement data and applies machine learning algorithms to detect brain health changes. An optional Research Platform module enables clinical research participation. The platform's primary test modality is the Smooth Pursuit (SMP) test, which captures ocular motor biomarkers to assess brain function. The company also operates a concussion research program conducted in partnership with Monash University.

Differentiator

Problem solved

Functional benefit

Products and services

  • BrainEye App

Quantifiable outcome

  • Traditional neurological examination evaluates approximately 10% of the brain, while BrainEye's assessment of the visual-ocular motor system evaluates over 50% of the brain
  • +1 more outcomes

Companies that use BrainEye

Customer profile

Segments5 records

Ideal customer profiles4 records

BrainEye technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

BrainEye partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Monash University Neuroscience DepartmentcoreStrategic or Co-development PartnerMonash University Neuroscience Department conducts independent research overseeing BioEye concussion trials. The partnership involves clinical validation of the BrainEye technology platform through rigorous scientific research.
  • AWS (Amazon Web Services)coreTechnology or IntegrationBrainEye processes and stores all data, including Personal Information, on secure AWS cloud servers. AWS provides the cloud infrastructure for the company's data processing, storage, and analysis operations.
  • Bellberry Human Research Ethics CommitteecoreOthersThe Bellberry Human Research Ethics Committee in Australia has reviewed and approved BrainEye's clinical research studies in accordance with the Australian National Statement on Ethical Conduct in Human Research.
  • Emmanuel PetitminorGTM or Marketing PartnerIconic French footballer and World Cup champion Emmanuel Petit serves as BrainEye Brand Ambassador, bringing global recognition and commitment to excellence to the mission of revolutionizing brain health. His advocacy helps connect with a wider audience, spreading awareness about managing brain health.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

BrainEye competitors and assessment

Company assessment

Direct peers

  • Oculogica: Eye-tracking concussion and neurological diagnostic platform (e.g., Eye-Sync/BOXS) commercialized to clinics and sports organizations — comparable eye-tracking modality and concussion GTM.
  • RightEye: Eye-tracking based health-assessment company whose core technology analyses ocular motility for brain/performance diagnostics — directly comparable to BrainEye's smooth-pursuit, ocular-motor biomarker approach.
  • Cumulus Neuroscience: Smartphone-based cognitive and neurological assessment platform using AI/ML on consumer devices to detect and monitor conditions such as depression, MS, and Alzheimer's — the closest direct competitor to BrainEye in modality and target.
  • SyncThink: Eye-tracking derived balance/concussion assessment tool used by sports teams and clinicians; the closest direct competitor in the sports/concussion sub-segment BrainEye explicitly targets.
  • Linus Health: Digital brain-health platform combining smartphone/tablet-based cognitive and speech assessment with AI for early detection of neurological impairment; overlaps BrainEye on smartphone-delivered, AI-analyzed brain biomarkers.

Broad incumbents

  • Akili Interactive: Public digital-therapeutics company with FDA-cleared, consumer-delivered cognitive assessment/intervention products; competes for the same at-home, smartphone-delivered brain-health user.
  • Cogstate: Established cognitive testing company serving clinical trials and healthcare providers; an incumbent in computerized brain-health assessment overlapping BrainEye's neurological-monitoring value proposition.
  • Cambridge Cognition: Provider of digital cognitive assessments used in clinical trials and research; comparable in the digital brain-health assessment and trials-services category.
  • Apple (Health / Vision Pro): Platform incumbent that ships eye-tracking, on-device ML, and a Health ecosystem across iPhone and Vision Pro — a primary platform risk for any smartphone/eye-tracking health play.

Emerging players

  • Posit Science (BrainHQ): Brain-training and cognitive-assessment platform targeting healthy-aging and clinical populations; overlaps BrainEye on longitudinal brain-health tracking and consumer health positioning.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

BrainEye social profiles

Digital presence

BrainEye financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BrainEye leadership team

Management profile

Number of profiles

Profiles6 records

BrainEye funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BrainEye M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BrainEye

What does BrainEye do?

BrainEye offers a smartphone-based eye-tracking application that measures brain health by tracking eye responses to visual stimuli in 60 seconds. The app captures ocular motor biomarkers via the smartphone camera, uploads them to a cloud platform, and applies AI/ML analysis to deliver real-time results that can indicate concussions, multiple sclerosis, Parkinson's disease, Alzheimer's disease, and other neurological conditions. Users subscribe via the Apple App Store or Google Play Store, with optional participation in clinical research through a separate research platform.

Is BrainEye a public or private company?

BrainEye is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was BrainEye founded?

BrainEye was founded in 2020. It employs 11 to 50 people.

Where is BrainEye based?

BrainEye is headquartered in Sydney, Australia, in the Oceania region.

How does BrainEye make money?

Two revenue lines are on record. App Subscription is the primary driver. The others are in-App Purchases.

Who are BrainEye's main competitors?

Direct peers on record are Oculogica, RightEye, Cumulus Neuroscience, SyncThink and Linus Health. Broad incumbents are Akili Interactive, Cogstate, Cambridge Cognition and Apple (Health / Vision Pro). Posit Science (BrainHQ) is listed as an emerging player.

Does BrainEye have an API?

No public API is recorded for BrainEye.

What industry is BrainEye in?

BrainEye's product category is Digital Health Brain Assessment Software. Its primary akta.pro industry code is HLALAGAC, Neurology Telemedicine Platforms, with a secondary code of HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables). Its NAICS code is 621320 and its SIC code is 3827.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales